PASITHEA THERAPEUTICS CORP (KTTA) Stock Analyst Earnings Estimates
NASDAQ:KTTA - Nasdaq - US70261F2020 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 15.1K | 510K -100.00% | |||
| EBITDA YoY % growth | N/A | -4.506M | -12.138M -179.27% | -9.486M -21.83% | |
| EBIT YoY % growth | -41K | -4.507M -10,893.66% | N/A -179.30% | N/A -26.93% | |
| Operating Margin | N/A | -29,850.33% | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -0.56 92.14% | -0.72 -29.09% |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2022 Q2Q % growth | -1.40 | -0.41 | -0.99 | -243.14% |
| Q4 2021 Q2Q % growth | 2.40 | -1.02 | 3.42 | 335.29% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | 13.6K | 510K | -496.4K | -97.33% |
| Q1 2022 Q2Q % growth | 306K | -306K | -100.00% | |
| Q4 2021 Q2Q % growth | 15.1K | 102K | -86.9K | -85.20% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |